Amber Scorah | 01/17/2011
New techniques for developing drug delivery mechanisms have led to two new particle engineering approaches that offer unique formula opportunities. Dr. Cory Berkland, Associate Professor at the University of Kansas, joins Amber Scorah from Pharma IQ, to talk about nanocluster technology and microcapsule approaches.
.
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2026
September 9 - 11, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More